BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«Sandhoff Disease

Below is an extended Sandhoff Disease research listing. Click here to return to the Sandhoff Disease main in depth entry.

Recent Publications on Sandhoff Disease:

Sphingosine kinase 1/S1P receptor signaling axis controls glial proliferation in mice with Sandhoff disease.
Sphingosine-1-phosphate (S1P) is a lipid-signaling molecule produced by...
Direct Link
5th August, 2008
Genetics of Development and Disease Branch, National Institute of Diabetes
Peripheral blood mononuclear cell infiltration and neuroinflammation in the HexB(-/-) mouse model of neurodegeneration.
Myeloid-derived immune cells, including microglia, macrophages and...
Direct Link
29th July, 2008
Department of Neurobiology & Anatomy, School of Medicine & Dentistry,
N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal Sandhoff disease mice.
Sandhoff disease involves the CNS accumulation of ganglioside GM2 and...
Direct Link
29th July, 2008
Biology Department, Boston College, 140 Commonwealth Avenue, Chestnut
Early deficits in motor coordination and cognitive dysfunction in a mouse model of the neurodegenerative lysosomal storage disorder, Sandhoff disease.
Mouse models of lysosomal storage diseases, including Sandhoff disease,...
Direct Link
10th July, 2008
Behavioral Core Facility, Dominick S. Purpura Department of Neuroscience,
Proton MRS of a child with Sandhoff disease reveals elevated brain hexosamine.
Sandhoff disease (gangliosidosis type 0) is a lysosomal storage disorder...
Direct Link
31st May, 2008
Abteilung Neuropadiatrie, Department of Pediatric Neurology, Klinikum
Imaging MALDI mass spectrometry using an oscillating capillary nebulizer matrix coating system and its application to analysis of lipids in brain from a mouse model of Tay-Sachs/Sandhoff disease.
The quality of tissue imaging by matrix-assisted laser...
Direct Link
21st May, 2008
School of Chemistry and Biochemistry, The Parker H. Petit Institute for
Simultaneous quantification of GM1 and GM2 gangliosides by isotope dilution tandem mass spectrometry.
OBJECTIVES: Gangliosides (GGs) are considered as diagnostic biomarkers and...
Direct Link
20th May, 2008
Department of Laboratory Medicine, Children's National Medical Center, 111
Involvement of Retinal Neurons and Pigment Epithelial Cells in a Murine Model of Sandhoff Disease.
Background/Aims: To investigate the effects of deficient degradation of...
Direct Link
26th April, 2008
Department of Developmental Morphology, Tokyo Metropolitan Institute for
Neuronal and glial accumulation of alpha- and beta-synucleins in human lipidoses.
A number of the lysosomal storage diseases that have now been...
Direct Link
20th February, 2008
Department of Psychiatry, Yokohama City University School of Medicine, 3-9
Substrate deprivation therapy: a new hope for patients suffering from neuronopathic forms of inherited lysosomal storage diseases. 29th January, 2008
Department of Molecular Biology, University of Gdansk, Kladki 24, 80-822
Increased lung surfactant phosphatidylcholine in patients affected by lysosomal storage diseases.
Sandhoff disease, Gaucher disease type I and sialidosis type I are...
Direct Link
9th January, 2008
Department of Neurological and Behavioural Sciences, Section of
Lending a helping hand, screening chemical libraries for compounds that enhance beta-hexosaminidase A activity in GM2 gangliosidosis cells.
Enzyme enhancement therapy is an emerging therapeutic approach that has...
Direct Link
19th December, 2007
Research Institute, SickKids, Toronto, Ontario, Canada.
Peripheral nervous system manifestations in a Sandhoff disease mouse model: nerve conduction, myelin structure, lipid analysis.
BACKGROUND: Sandhoff disease is an inherited lysosomal storage disease...
Direct Link
14th November, 2007
Biology Department, Boston College, 140 Commonwealth Avenue, Chestnut
Intraperitoneal inoculation of Sandhoff mouse neonates with an HIV-1 based lentiviral vector exacerbates the attendant neuroinflammation and disease phenotype.
We aimed to evaluate the efficacy of VSV-G pseudotyped, defective HIV-1...
Direct Link
20th October, 2007
Eastman Dental Center, University of Rochester School of Medicine and
The cranial base in craniofacial development: a gene therapy study. 18th October, 2007
Departments of Dentistry, School of Medicine and Dentistry, University of
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional